FI962985A0 - Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi - Google Patents

Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi

Info

Publication number
FI962985A0
FI962985A0 FI962985A FI962985A FI962985A0 FI 962985 A0 FI962985 A0 FI 962985A0 FI 962985 A FI962985 A FI 962985A FI 962985 A FI962985 A FI 962985A FI 962985 A0 FI962985 A0 FI 962985A0
Authority
FI
Finland
Prior art keywords
pct
preparation
dosage form
active ingredients
oral dosage
Prior art date
Application number
FI962985A
Other languages
English (en)
Swedish (sv)
Other versions
FI962985A (fi
FI116880B (fi
Inventor
Walter Mueller
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI962985A publication Critical patent/FI962985A/fi
Publication of FI962985A0 publication Critical patent/FI962985A0/fi
Application granted granted Critical
Publication of FI116880B publication Critical patent/FI116880B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI962985A 1994-01-27 1996-07-26 Menetelmä oraalisen lääkemuodon valmistamiseksi, jossa on kantaja happamalle vaikuttavalle aineelle FI116880B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
DE4402379 1994-01-27
EP9404082 1994-12-08
PCT/EP1994/004082 WO1995020394A1 (de) 1994-01-27 1994-12-08 Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
FI962985A FI962985A (fi) 1996-07-26
FI962985A0 true FI962985A0 (fi) 1996-07-26
FI116880B FI116880B (fi) 2006-03-31

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962985A FI116880B (fi) 1994-01-27 1996-07-26 Menetelmä oraalisen lääkemuodon valmistamiseksi, jossa on kantaja happamalle vaikuttavalle aineelle

Country Status (22)

Country Link
US (1) US5858344A (fi)
EP (1) EP0741574B1 (fi)
JP (1) JP3701971B2 (fi)
KR (1) KR100439311B1 (fi)
AT (1) ATE218371T1 (fi)
AU (1) AU697353B2 (fi)
CA (1) CA2182417C (fi)
CZ (1) CZ291006B6 (fi)
DE (2) DE4402379C2 (fi)
DK (1) DK0741574T3 (fi)
ES (1) ES2177622T3 (fi)
FI (1) FI116880B (fi)
HU (1) HU223317B1 (fi)
IL (1) IL112435A (fi)
MY (1) MY113340A (fi)
NO (1) NO963143L (fi)
NZ (1) NZ277777A (fi)
PL (1) PL315619A1 (fi)
PT (1) PT741574E (fi)
SK (1) SK97296A3 (fi)
WO (1) WO1995020394A1 (fi)
ZA (1) ZA95638B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
PL2561766T3 (pl) 2006-11-07 2018-06-29 The Procter And Gamble Company Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i stosowania
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
CA3222580A1 (en) 2021-06-07 2022-12-15 University Of Tsukuba Polymerized valproic acid and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
NZ277777A (en) 1997-01-29
FI962985A (fi) 1996-07-26
IL112435A0 (en) 1995-03-30
EP0741574A1 (de) 1996-11-13
SK97296A3 (en) 1997-04-09
NO963143L (no) 1996-09-24
EP0741574B1 (de) 2002-06-05
ES2177622T3 (es) 2002-12-16
MY113340A (en) 2002-01-31
HU9602041D0 (en) 1996-09-30
JP3701971B2 (ja) 2005-10-05
HUT74434A (en) 1996-12-30
KR100439311B1 (ko) 2005-08-17
AU697353B2 (en) 1998-10-01
AU1312795A (en) 1995-08-15
JPH09511488A (ja) 1997-11-18
DE59410133D1 (de) 2002-07-11
PL315619A1 (en) 1996-11-25
CA2182417A1 (en) 1995-08-03
DE4402379C2 (de) 1997-09-25
FI116880B (fi) 2006-03-31
DK0741574T3 (da) 2002-09-23
KR970700505A (ko) 1997-02-12
HU223317B1 (hu) 2004-05-28
NO963143D0 (no) 1996-07-26
US5858344A (en) 1999-01-12
ATE218371T1 (de) 2002-06-15
DE4402379A1 (de) 1995-08-03
IL112435A (en) 1999-01-26
CZ291006B6 (cs) 2002-11-13
CA2182417C (en) 2007-04-17
WO1995020394A1 (de) 1995-08-03
PT741574E (pt) 2002-11-29
CZ221396A3 (en) 1997-01-15
ZA95638B (en) 1995-10-25

Similar Documents

Publication Publication Date Title
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
EE04002B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
BR8801242A (pt) Processo de preparar uma composicao para fornecer uma quantidade efetiva de uma dose constante de um ingrediente ativo a um animal e a respectiva composicao
BG103552A (en) Therapeutical forms
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
DK0711154T3 (da) Stabiliseret farmaceutisk præparat indeholdende bupropion
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
BR9607926A (pt) Composição farmacêutica para o tratamento de hiperfosfatemia uso de carbonato de lantânio processo para a preparação de carbonato de lantânio e carbonato de lantânio
NZ501950A (en) Medicinal compositions for application to mucosa
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
TR199701294T1 (xx) Amoksisilin ve klavulanik asitten olu�an terkip.
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
NO174032C (no) Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
FI962985A0 (fi) Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi
BR9913718A (pt) Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
DE69624563T2 (de) Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
MY152490A (en) New oral formulation
UA29179A (uk) Спосіб профілактики карієсу зубів

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116880

Country of ref document: FI

MM Patent lapsed